on SARTORIUS STED BIO (EPA:DIM)
Sartorius Stedim Biotech Announces Share and Voting Rights Update
Sartorius Stedim Biotech SA has made a formal declaration regarding the number of shares and voting rights constituting its issued capital. This announcement, disseminated by EQS Group on August 2, 2024, provides key data as per French regulations.
As of July 31, 2024, Sartorius Stedim Biotech's total issued capital comprises 97,330,405 shares. The total number of theoretical voting rights, including treasury shares, stands at 165,568,221. The net voting rights, excluding treasury shares, slightly differ, totaling 165,541,761.
These figures are in accordance with Article L 233-8-II of the French Code of Commerce and Article 223-6 of the AMF's general regulations. This activity ensures compliance and provides transparency to stakeholders.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SARTORIUS STED BIO news